Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GERN | Employee Stock Option (right to buy) | Award | $0 | +250 K | $0.00 | 250 K | Jun 6, 2024 | Common Stock | 250 K | $3.21 | Direct | F1 |
Id | Content |
---|---|
F1 | Performance-based stock option granted on August 1, 2023 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS. |